India, Jan. 10 -- Johnson & Johnson (JNJ) announced new longer-term follow-up results from the investigational Phase 1b/2 OrigAMI-1 study evaluating RYBREVANT (amivantamab-vmjw), a bispecific antibody... Read More
India, Jan. 10 -- Contemporary Amperex Technology Co., Limited or CATL announced that it has inaugurated the Middle East's first-and currently the largest-new energy aftermarket facility outside China... Read More